GLYCOVISION
LIVE

Serial Number

97741761

Owner

Venn Biosciences Corporation

Attorney

Timothy D. Sitzmann

First Use Date

Aug 31, 2023

Filing Date

Jan 4, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GLYCOVISION Trademark

Serial Number: 97741761 • Registration: 7870915

GLYCOVISION is a trademark filed by Venn Biosciences Corporation on January 4, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Venn Biosciences Corporation (23 trademarks)

1001 Bayhill Drive, Suite 239
San Bruno, CA 94066

Entity Type: 03

Trademark Details

Filing Date

January 4, 2023

Registration Date

July 22, 2025

First Use Anywhere

August 31, 2023

First Use in Commerce

August 31, 2023

Published for Opposition

December 5, 2023

Goods & Services

Scientific and medical research services; scientific research, namely, identifying biomarkers for specific diseases; scientific research analysis services for blood and other bodily fluids, specifically, blood, bodily fluid, and biological specimen analysis services; scientific, technological, and medical research and data analysis services in the nature of bioanalytical testing services and biomarker discovery services; scientific and medical research in the fields of oncology, mass spectrometry, glycoproteomics, biomarker discovery; scientific, technological, and data analysis services, namely, glycoproteomic research, analysis services in the nature of protein, and a glycoproteomic solution featuring artificial intelligence; scientific and medical laboratory services; medical research services via collecting, analyzing, and reporting glycoproteomic data for blood, bodily fluids, and other biological specimens

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 22, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 22, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 16, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 28, 2025 CNPR
ASSIGNED TO EXAMINER
Jun 27, 2025 DOCK
STATEMENT OF USE PROCESSING COMPLETE
May 29, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 29, 2025 AITU
USE AMENDMENT FILED
Mar 5, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 5, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jan 8, 2025 EX2G
SOU EXTENSION 2 FILED
Jan 8, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 8, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jul 21, 2024 EX1G
SOU EXTENSION 1 FILED
Jul 21, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 21, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 30, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 5, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 27, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 27, 2023 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Sep 19, 2023 GPRN
PRIORITY ACTION E-MAILED
Sep 19, 2023 GPRA
PRIORITY ACTION WRITTEN
Sep 19, 2023 CPRA
ASSIGNED TO EXAMINER
Sep 12, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 29, 2023 NWOS
NEW APPLICATION ENTERED
Jan 7, 2023 NWAP